At the news
? BEARISHIMPACT 7/10 PRESS-RELEASE filed Jul 29, 2026 at 20:53 ET
Inovio Pharmaceuticals priced a $20M underwritten public offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at a combined price of $0.95 per share and accompanying warrant. The offering is highly dilutive, with the shares alone representing approximately 25% of the pre-offering share count, and the warrants could more than double the share count if exercised. This capital raise signals near-term cash needs and creates significant dilution for existing shareholders, which is bearish for the stock.
- Priced an underwritten public offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at a combined price of $0.95 per share and accompanying warrant.
- Gross proceeds expected to be approximately $20.0 million.
- Underwriter has a 30-day option to purchase up to 3,157,894 additional shares and/or warrants to purchase up to 6,315,788 additional shares.
- Offering expected to close on or about July 31, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access